Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
Author:
Funder
Shandong Medical and Health Development Plan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference31 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016
3. Risk factors and gene expression in esophageal cancer;Xu;Methods Mol Biol,2009
4. Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients;Akutsu;World J Surg,2009
5. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM classification for esophageal cancer;Talsma;Ann Surg Oncol,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma;Oncology;2024-07-22
2. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma;Cancer Biology & Therapy;2024-06-12
3. Advances in the Theranostics of Oesophageal Squamous Carcinoma;Advanced Therapeutics;2023-04-16
4. Longitudinal associations of serum survivin with the severity and prognosis of community-acquired pneumonia patients;Respiratory Investigation;2023-01
5. A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection;Frontiers in Oncology;2022-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3